American Oncology Network, Inc.
AONC
$9.15
-$0.09-0.97%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 135.09% | -110.91% | 135.83% | -427.66% | -375.33% |
| Total Depreciation and Amortization | 32.20% | 17.34% | 11.66% | 2.60% | 4.45% |
| Total Amortization of Deferred Charges | -100.00% | -17.51% | 21.47% | 22.16% | 28.40% |
| Total Other Non-Cash Items | 144.20% | 114.03% | -238.63% | -5,445.54% | -12,917.65% |
| Change in Net Operating Assets | -153.67% | -402.34% | -2,450.87% | 1,609.88% | 136.95% |
| Cash from Operations | 199.73% | -622.01% | -1,647.01% | 13,819.45% | -42.12% |
| Capital Expenditure | -129.54% | -145.51% | 1.89% | -48.79% | -28.66% |
| Sale of Property, Plant, and Equipment | -88.98% | -- | 2,720.00% | -- | -26.19% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.61% | 236.32% | 1,873.84% | 4,119.40% | -3,385.07% |
| Cash from Investing | -58.55% | 181.68% | 53.27% | 157.59% | -1,065.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -525.73% | -748.70% | -1,428.91% | -49.52% | -96.19% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 99.67% |
| Cash from Financing | 16,612.20% | -209.10% | -110.07% | -141.90% | 28.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 287.84% | 31.67% | -184.17% | 1,608.12% | -136.90% |